Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study

Annals of Oncology : Official Journal of the European Society for Medical Oncology
E R KoomenT Nijsten

Abstract

Multiple studies showed conflicting results on the association between oral contraceptive (OC) use and the development of cutaneous melanoma (CM). We investigated the association between estrogen use and CM incidence. Data from PHARMO Pharmacy database and PALGA, the pathology database in The Netherlands, were linked. Women, >or=18 years, with a pathology report of a primary CM from 1 January 1991 to 14 December 2004 and >or=3 years of follow-up before CM diagnosis were eligible cases. Controls were matched for age and geographic region. Multivariate logistic regression was used to calculate adjusted odds ratio (OR) and 95% confidence interval (CI) for the association between CM incidence and estrogen use, OCs and hormonal replacement therapy (HRT), separately. In total, 778 cases and 4072 controls were included. CM risk was significantly associated with estrogen use (>or=0.5 year; adjusted OR = 1.42, 95% CI 1.19-1.69). This effect was cumulative dose dependent (P trend < 0.001). CM risk was also significantly associated with the use of HRT (>or=0.5 year: OR = 2.08; 95% CI 1.37-3.14) and OC (>or=0.5 year: OR = 1.28; 95% CI 1.06-1.54). Our study suggests a cumulative dose-dependent increased risk of CM with the use of estrogens.

References

Nov 1, 1992·Cancer Causes & Control : CCC·J R PalmerS Shapiro
Sep 1, 1990·International Journal of Epidemiology·R ZanettiS Colonna
Dec 15, 1988·International Journal of Cancer. Journal International Du Cancer·A OsterlindO M Jensen
Nov 1, 1980·Southern Medical Journal·B S Schoenberg, B W Christine
May 1, 1997·Journal of Clinical Epidemiology·H S LauA Porsius
Nov 11, 1999·British Journal of Cancer·D FeskanichG A Colditz
Apr 16, 2002·British Journal of Cancer·M R KaragasA J Swerdlow
Sep 24, 2004·International Journal of Cancer. Journal International Du Cancer·Judit DobosAndrea Ladányi
Feb 3, 2005·Journal of the National Cancer Institute·Kathleen M EganWilliam J Blot
Mar 25, 2005·The British Journal of Dermatology·E de VriesJ W W Coebergh
Nov 2, 2006·Journal of the National Cancer Institute·Scott R FreemanRobert P Dellavalle
Apr 17, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E de VriesJ W W Coebergh
Oct 24, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E R KoomenH J Guchelaar
Nov 3, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E de VriesJ-W W Coebergh

❮ Previous
Next ❯

Citations

Dec 8, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I Franco-LieM Abdelnoor
Sep 1, 2011·Journal of the National Cancer Institute·Jean Y TangMarcia L Stefanick
Jul 13, 2012·Environmental Health : a Global Access Science Source·Katarina VolkovovaMaria Dusinska
Dec 18, 2013·American Journal of Surgery·Alison L BurtonGlenda G Callender
Jul 10, 2009·The Journal of Investigative Dermatology·Arjen JoosseTamar Nijsten
Jun 27, 2015·Human Reproduction·M M ReigstadR Storeng
Jun 15, 2010·Clinics in Dermatology·Amie Gupta, Marcia S Driscoll
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vincent O DezentjéHenk-Jan Guchelaar
Mar 16, 2017·Journal of Cancer Research and Clinical Oncology·Vincenzo De GiorgiSara Gandini
Feb 6, 2017·International Journal of Cancer. Journal International Du Cancer·Sang Min ParkEunyoung Cho
Jul 8, 2017·International Journal of Cancer. Journal International Du Cancer·Edoardo BotteriElisabete Weiderpass
Jan 10, 2018·International Journal of Cancer. Journal International Du Cancer·Bo LiQingyi Wei
Jul 7, 2018·International Journal of Cancer. Journal International Du Cancer·I CervenkaM Kvaskoff
Feb 13, 2019·The British Journal of Dermatology·N C StøerE Weiderpass
May 11, 2011·Expert Review of Anticancer Therapy·Vincenzo de GiorgiDaniela Massi
Sep 21, 2013·Melanoma Research·Louise M StewartRoger Hart
Jun 28, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Federica TomaoSilverio Tomao
Sep 12, 2019·International Journal of Cancer. Journal International Du Cancer·Iris CervenkaMarina Kvaskoff
Oct 31, 2019·American Journal of Epidemiology·Iris CervenkaMarina Kvaskoff
Nov 18, 2010·Expert Review of Anticancer Therapy·Esther Erdei, Salina M Torres
Oct 12, 2011·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Johan MoanAsta Juzeniene
Mar 1, 2019·British Journal of Cancer·Grayson M DonleyElizabeth K Cahoon
Apr 17, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·M AuriemmaP Amerio
Aug 2, 2015·Fertility and Sterility·Louise A BrintonCarolyn L Westhoff
Mar 2, 2011·Pediatrics·Sophie J BalkUNKNOWN Section on Dermatology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Epidemiology
Luigi NaldiOncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED)
Annals of Surgery
Charles R ScogginsSunbelt Melanoma Trial
Journal of the American Academy of Dermatology
Marcia S Driscoll, Jane M Grant-Kels
© 2022 Meta ULC. All rights reserved